Cargando…

Identification of the likely translational start of Mycobacterium tuberculosis GyrB

BACKGROUND: Bacterial DNA gyrase is a validated target for antibacterial chemotherapy. It consists of two subunits, GyrA and GyrB, which form an A(2)B(2) complex in the active enzyme. Sequence alignment of Mycobacterium tuberculosis GyrB with other bacterial GyrBs predicts the presence of 40 potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karkare, Shantanu, Brown, Amanda C, Parish, Tanya, Maxwell, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724585/ https://www.ncbi.nlm.nih.gov/pubmed/23856181 http://dx.doi.org/10.1186/1756-0500-6-274

Ejemplares similares

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014)

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
por: Feng, Xinyuan, et al.
Publicado: (2019)

The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage
por: Wu, Jinjun, et al.
Publicado: (2011)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

Identification of the translational start site of codon-optimized mCherry in Mycobacterium tuberculosis
por: Carroll, Paul, et al.
Publicado: (2014)

Multiplex gyrB PCR Assay for Identification of Acinetobacter baumannii Is Validated by Whole Genome Sequence-Based Assays
por: Albert, M. John, et al.
Publicado: (2022)

The role of Ca(2+) in the activity of Mycobacterium tuberculosis DNA gyrase
por: Karkare, Shantanu, et al.
Publicado: (2012)

Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR
por: Jayaraman, Premkumar, et al.
Publicado: (2013)

Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022)

Role of core promoter sequences in the mechanism of swarmer cell-specific silencing of gyrB transcription in Caulobacter crescentus
por: England, Jennifer C, et al.
Publicado: (2005)

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
por: Tari, Leslie W., et al.
Publicado: (2013)

A Novel Oligonucleotide Pair for Genotyping Members of the Pseudomonas Genus by Single-Round PCR Amplification of the gyrB Gene
por: Agaras, Betina Cecilia, et al.
Publicado: (2018)

Repeated Exposure of Escherichia coli to High Ciprofloxacin Concentrations Selects gyrB Mutants That Show Fluoroquinolone-Specific Hyperpersistence
por: Perault, Aurore, et al.
Publicado: (2022)

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection
por: Zhao, Xintong, et al.
Publicado: (2023)

A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function
por: Schoeffler, Allyn J., et al.
Publicado: (2010)

Characterization of non-classical quinolone resistance in Salmonella enterica serovar Typhi: Report of a novel mutation in gyrB gene and diagnostic challenges
por: Gupta, Ruchi, et al.
Publicado: (2015)

Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China
por: Qian, Huimin, et al.
Publicado: (2020)

Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019)

First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait
por: Al-Mutairi, Noura M, et al.
Publicado: (2011)

Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model
por: Jacobsson, Susanne, et al.
Publicado: (2022)

Phylogenomic Analysis Substantiates the gyrB Gene as a Powerful Molecular Marker to Efficiently Differentiate the Most Closely Related Genera Myxococcus, Corallococcus, and Pyxidicoccus
por: Liu, Yang, et al.
Publicado: (2021)

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections
por: Talley, Angela K., et al.
Publicado: (2021)

Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake
por: Brown, Amanda C, et al.
Publicado: (2008)

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
por: Park, Steven, et al.
Publicado: (2022)

The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA)
por: Huang, You-Yi, et al.
Publicado: (2006)

LytB1 and LytB2 of Mycobacterium tuberculosis Are Not Genetically Redundant
por: Brown, Amanda Claire, et al.
Publicado: (2015)

Genetic Diversity of Bacillus thuringiensis from Different Geo-Ecological Regions of Ukraine by Analyzing the 16S rRNA and gyrB Genes and by AP-PCR and saAFLP
por: Punina, N. V., et al.
Publicado: (2013)

Arabidopsis thaliana GYRB3 Does Not Encode a DNA Gyrase Subunit
por: Evans-Roberts, Katherine M., et al.
Publicado: (2010)

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis
por: Li, Jing, et al.
Publicado: (2014)

1288. Phase 1 First-in-Human Single- and Multiple-Ascending Dose Trial Demonstrates Pharmacokinetics (PK) and Tolerability of SPR720, an Oral DNA GyrB Inhibitor for Mycobacterial Infections
por: Talley, Angela, et al.
Publicado: (2020)

Mycobacterium tuberculosis ClpP Proteases Are Co-transcribed but Exhibit Different Substrate Specificities
por: Personne, Yoann, et al.
Publicado: (2013)

Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis
por: Anand, RS, et al.
Publicado: (2011)

Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
por: Collin, Frédéric, et al.
Publicado: (2011)

Identification of Novel Chemical Scaffolds that Inhibit the Growth of Mycobacterium tuberculosis in Macrophages
por: Ahmed, Sara, et al.
Publicado: (2022)

Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis
por: Wescott, Heather H., et al.
Publicado: (2018)

Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis
por: Thayer, Mai B., et al.
Publicado: (2021)

Correlation of gyr Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pn00feq12vkpia7dak7lua7m20